PRPO חוב כולל להון Precipio, Inc

Precipio, Inc. (PRPO) is implementing advanced oncology diagnostic methods for small laboratories, competing for market share against industry behemoths. The business's success relies on a team of expert pathologists for whom comfortable working conditions have been established. Current price action for the total debt-to-equity ratio is 0.24. Meanwhile, the company faces severe pressure from network operators who are undercutting prices through bundled offerings.

This indicator measures the proportion of borrowed funds within the financing structure, determining the business's degree of dependence on creditors relative to its own equity. For Precipio, Inc. (PRPO), with its scalable ICE-Cold PCR model and low Capex, an analysis of the total debt-to-equity ratio confirms the company's ability to grow without excessive leverage, ensuring high financial stability.